Exploratory study of paliperidone in patients with schizophrenia to investigate the safety and efficacy.

Trial Profile

Exploratory study of paliperidone in patients with schizophrenia to investigate the safety and efficacy.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs Paliperidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Janssen Pharmaceutical KK
  • Most Recent Events

    • 20 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top